[The effectiveness of using the enzyme inducer zixorin in the complex treatment of patients with viral hepatitis A].
Gnoevoĭ
V B
VB
Maksin
V R
VR
Zaika
V I
VI
Mosichev
Iu N
IuN
D000293:Adolescent; D000328:Adult; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004790:Enzyme Induction / Q000187:drug effects; D006506:Hepatitis A / Q000188:drug therapy*; D006801:Humans; D008070:Lipopolysaccharides / Q000627:therapeutic use; D008862:Microsomes, Liver / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000096:biosynthesis; D010634:Phenobarbital / Q000627:therapeutic use
D001559:Benzhydryl Compounds; D008070:Lipopolysaccharides; C009136:pyrogenal; D006899:Mixed Function Oxygenases; C016914:flumecinol; D010634:Phenobarbital
Effektivnost' primeneniia fermentativnogo induktora ziksorina v kompleksnom lechenii bol'nykh virusnym gepatititom A.